Thermal air hygiene technology for safer indoor environments.

Patented thermal air cleaning solution designed to inactivate airborne viruses in shared indoor spaces

Designed for continuous operation in

professional environments where air quality matters.

TECHNOLOGY

A NEW APPROACH TO AIR HYGIENE

TAC-30 uses a controlled thermal process to inactivate airborne viruses as air circulates through the device.

It delivers continuous air treatment without disposable filters or other  consumables.

The TAC-30 device is the first product implementation of our patented thermal air hygiene platform.

APPLICATION AREAS

Healthcare

Safer air for clinics, wards, and waiting rooms.

Business

Cleaner shared air in offices and meeting rooms.

Hospitality

Improved air hygiene for guests and staff indoors.

Industry

Continuous air treatment for production / controlled areas.

VALIDATION & IP

Validated in virological tests under controlled laboratory conditions.

CE-compliant, with TÜV Rheinland testing/validation.

Protected by international patents covering the core technology.

Engineered for robust, continuous operation.

For full details on test results, patents, and deployment plans:

Partner & Investor Opportunity

We’re opening discussions with strategic manufacturing and distribution partners, and with investors supporting the next stage of deployment.

Thermal Air Cleaner

Request Investor Deck

Share your details and we’ll send the deck
after a quick review of verified business emails.

WORK email only. Free addresses not accepted.
Please select your interest
PLEASE SELECT TICKET SIZE
Please Select One
  • Up to €250k
  • €250k - €1M
  • €1M - €5M
  • More than €5M
PLEASE STATE YOUR INVESTMENT FOCUS
0 of 350